Regulus, Glaxo Will Work on Hepatitis C Drugs

Thursday, 25 Feb 2010 02:36 PM

 

  Comment  |
   Contact  |
  Print   |
    A   A  
  Copy Shortlink

Drugmaker Regulus Therapeutics LLC said Thursday it is expanding a partnership with GlaxoSmithKline, and will begin researching new treatments for hepatitis C.

Regulus said it will identify a potential drug candidate in late 2010, and file an application with the Food and Drug Administration in 2011. Regulus said it could get more than $150 million from the new collaboration, along with royalty payments of up to 10 percent on sales of any drugs developed under the agreement.

Regulus is a joint venture between Alnylam Pharmaceuticals and Isis Pharmaceuticals. It develops drugs that use microRNA technology, which can turn parts of genes on or off to treat diseases.

GlaxoSmithKline and Regulus began collaborating in 2008 to develop four treatments for inflammatory diseases like rheumatoid arthritis. Regulus could get more than $600 million from that deal, along with royalty payments on sales.

Isis is based in Carlsbad, Calif., and Alnylam is headquartered in Cambridge, Mass. GlaxoSmithKline is located in the U.K. and it is one of the world's largest drugmakers.

In afternoon trading, Isis shares lost 4 cents to $8.79, and Alnylam shares fell 19 cents to $17.75. U.S.-traded shares of GlaxoSmithKline decreased 51 cents to $36.82.

© Copyright 2014 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

  Comment  |
   Contact  |
  Print   |
  Copy Shortlink
Around the Web
Join the Newsmax Community
Please review Community Guidelines before posting a comment.
>> Register to share your comments with the community.
>> Login if you are already a member.
blog comments powered by Disqus
 
Email:
Country
Zip Code:
Privacy: We never share your email.
 
Follow Newsmax
Like us
on Facebook
Follow us
on Twitter
Add us
on Google Plus
Around the Web
Top Stories
You May Also Like

New York Mayor de Blasio Named PETA's Person of the Year

Thursday, 18 Dec 2014 14:02 PM

New York Mayor Bill de Blasio was named 2014 Person of the Year by People for the Ethical Treatment of Animals (PETA) fo . . .

Quinnipiac: Only 47% of New Yorkers Support de Blasio

Thursday, 18 Dec 2014 13:56 PM

Support for Bill de Blasio's efforts as New York City mayor continues to decline as the gap between how black and whites . . .

Pension Deal in $1.1T Budget Bill Hits Retired Women Hard

Thursday, 18 Dec 2014 13:38 PM

Retired women who rely on their pensions to purchase necessities like food and medicine will be the ones hurt most by a  . . .

Most Commented

Newsmax, Moneynews, Newsmax Health, and Independent. American. are registered trademarks of Newsmax Media, Inc. Newsmax TV, and Newsmax World are trademarks of Newsmax Media, Inc.

 
NEWSMAX.COM
America's News Page
©  Newsmax Media, Inc.
All Rights Reserved